BioCryst Pharmaceuticals, Inc. Net Income

Net Income of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Income growth rates and interactive chart. Net income (NI), also called net earnings, is calculated as sales minus cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes, and other expenses. It is the profit available to all shareholders, both preferred and common.

Highlights and Quick Summary

  • Net Income for the quarter ending September 30, 2022 was $-42.5 Million (a -27.76% decrease compared to previous quarter)
  • Year-over-year quarterly Net Income increased by 139.16%
  • Annual Net Income for 2021 was $-184 Million (a 0.68% increase from previous year)
  • Annual Net Income for 2020 was $-183 Million (a 67.88% increase from previous year)
  • Annual Net Income for 2019 was $-109 Million (a 7.55% increase from previous year)
  • Twelve month Net Income ending September 30, 2022 was $-193 Million (a -7.77% decrease compared to previous quarter)
  • Twelve month trailing Net Income increased by 5.05% year-over-year
Trailing Net Income for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$-193 Million $-210 Million $-194 Million $-184 Million
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Income of BioCryst Pharmaceuticals, Inc.

Most recent Net Incomeof BCRX including historical data for past 10 years.

Interactive Chart of Net Income of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. Net Income for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – $-42.52 $-58.86 $-74.2 –
2021 $-17.78 $-58.8 $-43.2 $-64.28 $-184.06
2020 $-60.49 $-46.12 $-38.61 $-37.6 $-182.81
2019 $-2.62 $-37.59 $-37.63 $-31.05 $-108.9
2018 $-27.43 $-29.6 $-18.45 $-25.78 $-101.25
2017 $-19.54 $-15.13 $-16.89 $-14.22 $-65.78
2016 $-4.5 $-11.53 $-16.28 $-22.83 $-55.14
2015 $-18.14 $-14.62 $4.9 $-15.16 $-43.02
2014 $-11.67 $-8.73 $-14.65 $-10.14 $-45.19
2013 $-5.43 $-8.0 $-12.17 $-4.51 $-30.11
2012 $-11.05 $-9.7 $-12.28 $-6.05 $-39.08

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com